Whats Wrong With Bruce Willis?

Bruce Willis has frontotemporal dementia, a progressive brain disease that damages the frontal and temporal lobes of the brain. His family announced his retirement from acting in 2022 after he was diagnosed with aphasia, a condition that affects language. In 2023, his family shared that his condition had progressed and that his diagnosis was now frontotemporal dementia, often shortened to FTD.

FTD is not Alzheimer’s disease. It is a different form of dementia with different symptoms, a different average age of onset, and a different pattern of brain damage. Understanding what FTD is, and what it is not, helps make sense of what Bruce Willis and his family are facing.

What Is Frontotemporal Dementia?

Frontotemporal dementia is a group of brain disorders caused by the progressive loss of nerve cells in the frontal and temporal lobes. These are the areas of the brain located behind the forehead and behind the ears. They govern personality, behavior, language, and the ability to plan and organize.

When these regions shrink, the changes show up in how a person behaves and communicates, often long before memory problems appear. That pattern is one of the defining features of FTD and a key difference from Alzheimer’s disease, which typically begins with memory loss.

FTD is relatively rare. It is estimated to account for roughly 10 to 20 percent of all dementia cases, though estimates vary. It is, however, one of the most common causes of dementia in people under age 60. The typical age of onset is between 45 and 65, but cases in the 30s and 70s have been documented.

How Is FTD Different From Alzheimer’s Disease?

Alzheimer’s disease and FTD are distinct conditions with distinct causes and distinct symptom patterns. The confusion between them is common because both are forms of dementia and both are progressive.

In Alzheimer’s disease, the earliest and most prominent symptom is usually trouble remembering recent events. In FTD, memory often stays relatively intact in the early stages. Instead, the first changes tend to involve personality, behavior, or language.

The underlying biology also differs. Alzheimer’s disease is characterized by the buildup of abnormal proteins called amyloid plaques and tau tangles throughout the brain. FTD involves abnormal forms of the tau protein or another protein called TDP-43, but it does not involve the amyloid plaques that define Alzheimer’s. This is why Alzheimer’s medications, which target the cholinergic system, generally do not help people with FTD.

What Are the Symptoms of Frontotemporal Dementia?

FTD symptoms fall into two broad patterns, depending on which part of the brain is affected first. Some people develop behavior and personality changes. Others develop language problems. Many eventually develop both.

The behavioral variant is the most common form. It often begins with changes that family members notice before the person does. Someone who was once considerate may become impulsive or say things that are socially inappropriate. Apathy, or a loss of interest in things the person used to enjoy, is common. So is a decline in personal hygiene or a lack of empathy for others.

Some people develop repetitive behaviors or fixate on certain routines. Compulsive eating, especially a preference for sweets or overeating, has been reported. These changes can be mistaken for depression, a midlife crisis, or a psychiatric condition, which is one reason FTD is often misdiagnosed early on.

The language variant, called primary progressive aphasia, affects the ability to speak or understand words. In one form, a person struggles to find the right word or speak fluently but still understands what others say. In another form, the person has trouble understanding the meaning of words, even though speech remains fluent. Bruce Willis’s initial diagnosis of aphasia fits this language-first pattern.

What Causes FTD and Who Is at Risk?

The exact cause of most FTD cases is not known. The disease results from the abnormal accumulation of proteins that damage nerve cells, but what triggers that process in any given person is largely unclear.

Genetics play a larger role in FTD than in most other dementias. About a third of people with FTD have a family member with the condition or a related disorder. Several gene mutations have been linked to inherited forms of FTD, including mutations in the C9orf72, MAPT, and GRN genes. That said, most cases are not clearly inherited, and having a family history does not guarantee someone will develop FTD.

Unlike Alzheimer’s disease, age is less of a risk factor for FTD because it tends to strike earlier in life. There is no established link between FTD and lifestyle factors like diet, exercise, or smoking in the way there is for some other forms of dementia. No screening test currently exists to predict who will develop FTD.

How Is FTD Diagnosed?

There is no single test that confirms FTD. Diagnosis is based on a combination of clinical evaluation, imaging, and ruling out other conditions.

A neurologist typically assesses behavior, language, and cognitive function through structured interviews and tests. Brain imaging, usually an MRI or a PET scan, can reveal shrinkage in the frontal and temporal lobes. Because the symptoms of FTD overlap with those of Alzheimer’s, psychiatric disorders, and other conditions, the diagnostic process can take time. On average, people with FTD wait longer for an accurate diagnosis than people with Alzheimer’s, partly because the condition is less well known.

Genetic testing may be recommended when there is a strong family history. It is not routine for everyone.

What Treatments Are Available for FTD?

No treatment currently slows or stops the progression of frontotemporal dementia. This is an important and honest point. The medications approved for Alzheimer’s disease have not been shown to help FTD, and in some cases they can worsen behavioral symptoms.

Management focuses on easing symptoms and supporting quality of life. Some clinicians prescribe certain antidepressants or antipsychotic medications to manage behavioral symptoms, though the evidence for these is limited and they carry their own risks. Behavioral approaches, speech therapy, and occupational therapy can help people adapt as the disease progresses. Physical therapy may help with movement problems that develop later.

Because FTD affects behavior and judgment, safety becomes a growing concern. People with FTD may make poor financial decisions, drive unsafely, or fail to recognize hazards. Planning for care and legal matters early, while the person can still participate, is commonly recommended by clinicians.

The disease is progressive. Life expectancy after symptoms begin is typically described as roughly 6 to 8 years, though this varies widely from person to person. Some people live considerably longer.

Why Is FTD Often Misunderstood?

FTD is misunderstood for a few reasons. It is rare compared to Alzheimer’s, so public awareness is lower. Its symptoms in the early stages look like personality flaws or psychiatric illness rather than a neurological disease. And because it strikes people in midlife, it disrupts careers, families, and finances at a stage when those disruptions are least expected.

This is part of why the Willis family’s decision to share his diagnosis publicly mattered. When a well-known person speaks openly about a rare disease, it can shorten the time it takes for others to recognize similar symptoms and seek evaluation. It also helps reduce the stigma that surrounds conditions that affect behavior and personality.

For families navigating an FTD diagnosis, organizations like the Association for Frontotemporal Degeneration provide information and support. A neurologist familiar with FTD is a better resource than a general practitioner for questions about care and progression.